Organogenesis

$4.72 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Organogenesis

Organogenesis Holdings Inc. operates as a holding company. The Company, through its subsidiaries, focuses on development, manufacturing, and commercializing drugs and medicines for wound care, surgical, and sports medicine markets. Organogenesis Holdings serves customers in the United States and Switzerland.

Stock Analysis

last close $4.78
1-mo return -3%
3-mo return -18.7%
avg daily vol. 911.8T
52-week high 17.5
52-week low 4.62
market cap. $799M
forward pe 13.1
annual div. -
roe 42.5%
ltg forecast -
dividend yield -
annual rev. $464M
inst own. 46.2%
baraka

Subscribe now for daily local and international financial news

Subscribe